SHPL-49
/ Hutchmed
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 22, 2025
SAIL: Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke
(clinicaltrials.gov)
- P3 | N=1096 | Not yet recruiting | Sponsor: Shanghai Hutchison Pharmaceuticals Limited
New P3 trial • Cardiovascular • Ischemic stroke
1 to 1
Of
1
Go to page
1